Cart
sales@molnova.com
Trapencaine
CAS No. 76629-91-9
Trapencaine( —— )
Catalog No. M36243 CAS No. 76629-91-9
Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 126 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 307 | In Stock |
|
| 50MG | 421 | In Stock |
|
| 100MG | 570 | In Stock |
|
| 200MG | 768 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTrapencaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
-
DescriptionTrapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76629-91-9
-
Formula Weight374.52
-
Molecular FormulaC22H34N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C(NC1=CC(OCCCCC)=CC=C1)=O)C2C(CCCC2)N3CCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SB-237376 HCl
SB-237376 HCl (SB-237376 hydrochloride) is a calcium and potassium channel antagonist used in the treatment of cardiac arrhythmias.
-
LTGO-33
LTGO-33 is a species-specific inhibitor of the voltage-gated sodium channel NaV1.8, inhibiting NaV1.8, NaV1.1-NaV1.7, and NaV1.9.
-
Suzetrigine
Suzetrigine（VX-548） is an orally active and specific NaV1.8 inhibitor. Suzetrigine has analgesic activity and can be used to study acute pain and neurotransmission.
